Keywords: novartis, sales, down, forecasts, swiss, health, care
Novartis 1998 sales down on forecasts
Article | 21 January 1999
Swiss health care and nutrition company Novartis has reported 1998 groupsales of 31.7 billion Swiss francs ($22.94 billion), a rise of 2%, or 5% in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
